Literature DB >> 32157320

[Influence of genetics in intracranial aneurysms].

P Dietrich1.   

Abstract

BACKGROUND: The prevalence of unruptured intracranial aneurysms is approximately 3-5%. Subarachnoid hemorrhage caused by rupture of an aneurysm often affects middle-aged people and harbors high morbidity and mortality. The increasing availability of noninvasive imaging techniques over time is accompanied by an increase in the incidental detection of aneurysms.
METHODS: The etiology in aneurysm development is heterogeneous. Besides polygenic multifactorial diseases, often triggered by well-established vascular risk factors, monogenic diseases should also be considered. Advances in genetics has helped to identify genes that contribute to the risk of intracranial aneurysm development.
CONCLUSION: The genetic basis of intracranial aneurysms shows a broad heterogeneity and complexity. Currently, besides imaging there is no reliable diagnostic test to identify patients who are at higher risk for asymptomatic intracranial aneurysms.

Entities:  

Keywords:  Aneurysm, ruptured; Genetics; Hereditary disease; Risk factors; Subarachnoid hemorrhage

Year:  2020        PMID: 32157320     DOI: 10.1007/s00117-020-00663-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  25 in total

1.  Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study.

Authors:  R Bonita
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

Review 2.  Whole exome sequencing of intracranial aneurysm.

Authors:  Tatiana Foroud
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

Review 3.  Genetic investigations on intracranial aneurysm: update and perspectives.

Authors:  Romain Bourcier; Richard Redon; Hubert Desal
Journal:  J Neuroradiol       Date:  2015-02-09       Impact factor: 3.447

Review 4.  Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review.

Authors:  Federico Cagnazzo; Carlo Gambacciani; Riccardo Morganti; Paolo Perrini
Journal:  Acta Neurochir (Wien)       Date:  2017-03-10       Impact factor: 2.216

5.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

6.  Prevalence of Intracranial Aneurysms in Patients with Connective Tissue Diseases: A Retrospective Study.

Authors:  S T Kim; W Brinjikji; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-18       Impact factor: 3.825

Review 7.  Is Marfan syndrome associated with symptomatic intracranial aneurysms?

Authors:  J S van den Berg; M Limburg; R C Hennekam
Journal:  Stroke       Date:  1996-01       Impact factor: 7.914

8.  Epidemiology and genetics of intracranial aneurysms.

Authors:  F Caranci; F Briganti; L Cirillo; M Leonardi; M Muto
Journal:  Eur J Radiol       Date:  2013-02-08       Impact factor: 3.528

Review 9.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

Review 10.  Genetics of intracranial aneurysms.

Authors:  Ynte M Ruigrok; Gabriel J E Rinkel
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  1 in total

1.  Intracranial Aneurysms Induced by RUNX1 Through Regulation of NFKB1 in Patients With Hypertension-An Integrated Analysis Based on Multiple Datasets and Algorithms.

Authors:  Yang Li; Zhen Zhang; Donghua Liu
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.